Literature DB >> 19516960

Genomic instability and carcinogenesis: an update.

Wael M Abdel-Rahman1.   

Abstract

Cancers arise as a result of stepwise accumulation of mutations which may occur at the nucleotide level and/or the gross chromosomal level. Many cancers particularly those of the colon display a form of genomic instability which may facilitate and speed up tumor initiation and development. In few instances, a "mutator mutation" has been clearly implicated in driving the accumulation of other carcinogenic mutations. For example, the post-replicative DNA mismatch repair deficiency results in dramatic increase in insertion/deletion mutations giving rise to the microsatellite instability (MSI) phenotype and may predispose to a spectrum of tumours when it occurs in the germline. Although many sporadic cancers show multiple mutations suggesting unstable genome, the role of this instability in carcinogenesis, as opposed to the power of natural selection, has been a matter of controversy. This review gives an update of the latest data on these issues particularly recent data from genome-wide, high throughput techniques as well as mathematical modelling. Throughout this review, reference will be made to the relevance of genomic instability to the pathogenesis of colorectal carcinoma particularly its hereditary and familial subsets.

Entities:  

Keywords:  Genetic instability; Genomic instability; HNPCC; Lynch syndrome; chromosomal instability; colorectal cancer; familial colorectal cancer type-X; microsatellite instability; mismatch repair.

Year:  2008        PMID: 19516960      PMCID: PMC2694557          DOI: 10.2174/138920208786847926

Source DB:  PubMed          Journal:  Curr Genomics        ISSN: 1389-2029            Impact factor:   2.236


  76 in total

1.  Heredity and DNA methylation in colorectal cancer.

Authors:  J R Jass
Journal:  Gut       Date:  2007-01       Impact factor: 23.059

2.  Validation and extension of the PREMM1,2 model in a population-based cohort of colorectal cancer patients.

Authors:  Francesc Balaguer; Judith Balmaña; Sergi Castellví-Bel; Ewout W Steyerberg; Montserrat Andreu; Xavier Llor; Rodrigo Jover; Sapna Syngal; Antoni Castells
Journal:  Gastroenterology       Date:  2007-10-26       Impact factor: 22.682

3.  Prediction of germline mutations and cancer risk in the Lynch syndrome.

Authors:  Sining Chen; Wenyi Wang; Shing Lee; Khedoudja Nafa; Johanna Lee; Kathy Romans; Patrice Watson; Stephen B Gruber; David Euhus; Kenneth W Kinzler; Jeremy Jass; Steven Gallinger; Noralane M Lindor; Graham Casey; Nathan Ellis; Francis M Giardiello; Kenneth Offit; Giovanni Parmigiani
Journal:  JAMA       Date:  2006-09-27       Impact factor: 56.272

4.  Frequent loss of hMLH1 by promoter hypermethylation leads to microsatellite instability in adenomatous polyps of patients with a single first-degree member affected by colon cancer.

Authors:  Luigi Ricciardiello; Ajay Goel; Vilma Mantovani; Tania Fiorini; Stefania Fossi; Dong K Chang; Veronica Lunedei; Paolo Pozzato; Rocco M Zagari; Luca De Luca; Lorenzo Fuccio; Giuseppe N Martinelli; Enrico Roda; C Richard Boland; Franco Bazzoli
Journal:  Cancer Res       Date:  2003-02-15       Impact factor: 12.701

5.  Altered expression of MLH1, MSH2, and MSH6 in predisposition to hereditary nonpolyposis colorectal cancer.

Authors:  Elise Renkonen; Yange Zhang; Hannes Lohi; Reijo Salovaara; Wael M Abdel-Rahman; Mef Nilbert; Kristiina Aittomaki; Heikki J Jarvinen; Jukka-Pekka Mecklin; Annika Lindblom; Paivi Peltomaki
Journal:  J Clin Oncol       Date:  2003-10-01       Impact factor: 44.544

6.  Loss of the wild type MLH1 gene is a feature of hereditary nonpolyposis colorectal cancer.

Authors:  A Hemminki; P Peltomäki; J P Mecklin; H Järvinen; R Salovaara; M Nyström-Lahti; A de la Chapelle; L A Aaltonen
Journal:  Nat Genet       Date:  1994-12       Impact factor: 38.330

Review 7.  Molecular basis and diagnostics of hereditary colorectal cancers.

Authors:  Wael M Abdel-Rahman; Päivi Peltomäki
Journal:  Ann Med       Date:  2004       Impact factor: 4.709

8.  Association of the CpG island methylator phenotype with family history of cancer in patients with colorectal cancer.

Authors:  Marsha L Frazier; Lixuan Xi; Jihong Zong; Nancy Viscofsky; Asif Rashid; Elsie F Wu; Patrick M Lynch; Christopher I Amos; Jean-Pierre J Issa
Journal:  Cancer Res       Date:  2003-08-15       Impact factor: 12.701

Review 9.  The significance of unstable chromosomes in colorectal cancer.

Authors:  Harith Rajagopalan; Martin A Nowak; Bert Vogelstein; Christoph Lengauer
Journal:  Nat Rev Cancer       Date:  2003-09       Impact factor: 60.716

10.  Little evidence for involvement of MLH3 in colorectal cancer predisposition.

Authors:  Tuija Hienonen; Päivi Laiho; Reijo Salovaara; Jukka-Pekka Mecklin; Heikki Järvinen; Pertti Sistonen; Päivi Peltomäki; Rainer Lehtonen; Nina N Nupponen; Virpi Launonen; Auli Karhu; Lauri A Aaltonen
Journal:  Int J Cancer       Date:  2003-08-20       Impact factor: 7.396

View more
  16 in total

1.  Cancer-stromal cell fusion as revealed by fluorescence protein tracking.

Authors:  Ruoxiang Wang; Michael S Lewis; Ji Lyu; Haiyen E Zhau; Stephen J Pandol; Leland W K Chung
Journal:  Prostate       Date:  2019-12-17       Impact factor: 4.104

Review 2.  The Endocrine Disruptor Bisphenol A (BPA) Exerts a Wide Range of Effects in Carcinogenesis and Response to Therapy.

Authors:  Shirin A Hafezi; Wael M Abdel-Rahman
Journal:  Curr Mol Pharmacol       Date:  2019       Impact factor: 3.339

3.  A model for random genetic damage directing selection of diploid or aneuploid tumours.

Authors:  P S Bazeley; A L Nestor Kalinoski; J A Ways; S-T Liu; R S Ramdath; S-i Matsui; D C Allison
Journal:  Cell Prolif       Date:  2011-06       Impact factor: 6.831

4.  Phylostratigraphic tracking of cancer genes suggests a link to the emergence of multicellularity in metazoa.

Authors:  Tomislav Domazet-Loso; Diethard Tautz
Journal:  BMC Biol       Date:  2010-05-21       Impact factor: 7.431

5.  Gene expression signature discriminates sporadic from post-radiotherapy-induced thyroid tumors.

Authors:  Catherine Ory; Nicolas Ugolin; Céline Levalois; Ludovic Lacroix; Bernard Caillou; Jean-Michel Bidart; Martin Schlumberger; Ibrahima Diallo; Florent de Vathaire; Paul Hofman; José Santini; Bernard Malfoy; Sylvie Chevillard
Journal:  Endocr Relat Cancer       Date:  2011-01-19       Impact factor: 5.678

6.  A mathematical methodology for determining the temporal order of pathway alterations arising during gliomagenesis.

Authors:  Yu-Kang Cheng; Rameen Beroukhim; Ross L Levine; Ingo K Mellinghoff; Eric C Holland; Franziska Michor
Journal:  PLoS Comput Biol       Date:  2012-01-05       Impact factor: 4.475

7.  Effect of dedifferentiation on time to mutation acquisition in stem cell-driven cancers.

Authors:  Alexandra Jilkine; Ryan N Gutenkunst
Journal:  PLoS Comput Biol       Date:  2014-03-06       Impact factor: 4.475

8.  Migration of mitochondrial DNA in the nuclear genome of colorectal adenocarcinoma.

Authors:  Vinodh Srinivasainagendra; Michael W Sandel; Bhupendra Singh; Aishwarya Sundaresan; Ved P Mooga; Prachi Bajpai; Hemant K Tiwari; Keshav K Singh
Journal:  Genome Med       Date:  2017-03-29       Impact factor: 11.117

9.  Expanding the phenotype of E318K (c.952G > A) MITF germline mutation carriers: case series and review of the literature.

Authors:  Leandro Jonata Carvalho Oliveira; Aline Bobato Lara Gongora; Fabiola Ambrosio Silveira Lima; Felipe Sales Nogueira Amorim Canedo; Carla Vanessa Quirino; Janina Pontes Pisani; Maria Isabel Achatz; Benedito Mauro Rossi
Journal:  Hered Cancer Clin Pract       Date:  2021-07-21       Impact factor: 2.857

10.  High incidence of microsatellite instability and loss of heterozygosity in three loci in breast cancer patients receiving chemotherapy: a prospective study.

Authors:  Nasir Kamat; Mohammed A Khidhir; Mohammed Jaloudi; Sabir Hussain; Mouied M Alashari; Khaled H Al Qawasmeh; Ulf Rannug
Journal:  BMC Cancer       Date:  2012-08-28       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.